124 related articles for article (PubMed ID: 38356418)
1. Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors.
Taher ES; Marzouk AA; Abd-Allah WH; Giovannuzzi S; Ibrahim TS; Supuran CT; El Hamd MA; El-Behairy MF
ChemMedChem; 2024 May; 19(10):e202400004. PubMed ID: 38356418
[TBL] [Abstract][Full Text] [Related]
2. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307
[TBL] [Abstract][Full Text] [Related]
4. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
5. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
7. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
8. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT
Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
10. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
16. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
17. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors.
Swain B; Marde VS; Singh P; Angeli A; Khan A; Yaddanapudi VM; Ullah Q; Supuran CT; Arifuddin M
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300718. PubMed ID: 38466120
[TBL] [Abstract][Full Text] [Related]
20. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
